NO964346L - Fremgangsmåte for opplösning av Etodolac ved bruk av glukaminderivater - Google Patents
Fremgangsmåte for opplösning av Etodolac ved bruk av glukaminderivaterInfo
- Publication number
- NO964346L NO964346L NO964346A NO964346A NO964346L NO 964346 L NO964346 L NO 964346L NO 964346 A NO964346 A NO 964346A NO 964346 A NO964346 A NO 964346A NO 964346 L NO964346 L NO 964346L
- Authority
- NO
- Norway
- Prior art keywords
- etodolac
- pct
- glucamine
- dissolving
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Salter av glukamin eller N-(CMaIkyl)glukamin (formel 1) med S-etodolac, (formel 2) fortrinnsvis med gluminsaltet, er spesielt egnet for rakst innsettende analgetisk virkning. Disse saltene kan fremstilles ved å oppløse racemisk etodolac ved bruk av glukamin eller et N-(CMalkyI)glukamin som oppløsningsmiddel. I tillegg kan vannløselig S-etodolacsalter generelt anvendes ved fremstilling av medikamenter for bruk i hurtig innsettende analgesi og ved kontroll av kronisk smerte, og er spesielt egnet for formuleringer med vedvarende frigjøring.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9407225A GB9407225D0 (en) | 1994-04-12 | 1994-04-12 | Chiroscience limited |
GBGB9501455.1A GB9501455D0 (en) | 1995-01-25 | 1995-01-25 | Analgesic agent and its use |
PCT/GB1995/000857 WO1995027713A1 (en) | 1994-04-12 | 1995-04-11 | Process for the resolution of etodolac using glucamine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
NO964346D0 NO964346D0 (no) | 1996-10-11 |
NO964346L true NO964346L (no) | 1996-12-11 |
Family
ID=26304688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO964346A NO964346L (no) | 1994-04-12 | 1996-10-11 | Fremgangsmåte for opplösning av Etodolac ved bruk av glukaminderivater |
Country Status (9)
Country | Link |
---|---|
US (1) | US5811558A (no) |
EP (1) | EP0755398B1 (no) |
JP (1) | JPH09511516A (no) |
AT (1) | ATE221533T1 (no) |
AU (1) | AU2220695A (no) |
DE (1) | DE69527617T2 (no) |
ES (1) | ES2177644T3 (no) |
NO (1) | NO964346L (no) |
WO (1) | WO1995027713A1 (no) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5574183A (en) * | 1995-01-24 | 1996-11-12 | Albemarle Corporation | Preparation of optically active aliphatic carboxylic acids |
US6399093B1 (en) | 1999-05-19 | 2002-06-04 | Advanced Medical Instruments | Method and composition to treat musculoskeletal disorders |
US7151100B1 (en) | 1999-07-23 | 2006-12-19 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US7361680B2 (en) * | 1999-07-23 | 2008-04-22 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US6545034B1 (en) | 1999-07-23 | 2003-04-08 | The Regents Of The University Of California | Use of etodolac for the treatment of chronic lymphocytic leukemia |
US7129262B2 (en) * | 1999-07-23 | 2006-10-31 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US7105560B1 (en) | 1999-07-23 | 2006-09-12 | The Regents Of The University Of California | Use of etodolac in the treatment of multiple myeloma |
GB0007239D0 (en) * | 2000-03-24 | 2000-05-17 | Nycomed Imaging As | Use |
US20040152672A1 (en) * | 2000-08-09 | 2004-08-05 | Carson Dennis A. | Indole compounds useful for the treatment of cancer |
US7601846B2 (en) * | 2001-06-26 | 2009-10-13 | The Regents Of The University Of California | Compounds having activity as inhibitors of apoptosis |
US20030232794A1 (en) * | 2001-06-26 | 2003-12-18 | Cottam Howard B. | Use of STAT-6 inhibitors as therapeutic agents |
GB0206505D0 (en) * | 2002-03-19 | 2002-05-01 | Euro Celtique Sa | Pharmaceutical combination |
AU2003295336A1 (en) * | 2002-09-19 | 2004-04-08 | Dennis A. Carson | Use of etodoclac to treat hyperplasia |
ITMI20031471A1 (it) | 2003-07-18 | 2005-01-19 | Chemi Spa | Processo per la racemizzazione dell'acido etodolico |
SI3056492T1 (sl) | 2004-10-08 | 2022-03-31 | Abbvie Inc. | Sol meglumina in njene kristalinične oblike zdravila (delafloksacin) |
MX2007012642A (es) * | 2005-04-11 | 2008-01-11 | Abbott Lab | Composiciones farmaceuticas que tienen perfiles mejorados de disolucion para farmacos poco solubles. |
ITMI20060894A1 (it) | 2006-05-05 | 2007-11-06 | Univ Catania | Ciclodestrine funzionalizzate con etodolac come agenti di rilascio sito specifico |
CA2653941C (en) | 2006-05-31 | 2013-01-08 | The Regents Of The University Of California | Substituted amino purine derivatives and uses thereof |
CN102850204B (zh) * | 2011-06-29 | 2015-08-19 | 徐州医学院 | 一种(s)-2-芳基丙酸类非甾体抗炎药的拆分方法 |
WO2013169218A1 (en) | 2012-05-08 | 2013-11-14 | Mahmut Bilgic | Pharmaceutical compositions of s-etodolac |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4520203A (en) * | 1983-08-16 | 1985-05-28 | American Home Products Corporation | Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cinchonine |
US4501899A (en) * | 1983-08-16 | 1985-02-26 | American Home Products Corporation | Resolution of (+)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cholesteryl aniline |
US4544757A (en) * | 1984-02-16 | 1985-10-01 | American Home Products Corporation | Process for the resolution of pyrano[3,4-b]indole-1-acetic acids |
IT1207994B (it) * | 1986-01-03 | 1989-06-01 | Therapicon Srl | Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche. |
GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
EP0408496A3 (en) * | 1989-07-12 | 1992-07-01 | Ciba-Geigy Ag | Solid dosage form for pharmaceutical substances |
US5256293A (en) * | 1991-09-20 | 1993-10-26 | Research Corporation Technologies, Inc. | Separation of enantiomers of non-steroidal anti-inflammatory drugs and chiral selector therefor |
-
1995
- 1995-04-11 US US08/727,503 patent/US5811558A/en not_active Expired - Fee Related
- 1995-04-11 WO PCT/GB1995/000857 patent/WO1995027713A1/en active IP Right Grant
- 1995-04-11 DE DE69527617T patent/DE69527617T2/de not_active Expired - Fee Related
- 1995-04-11 ES ES95915264T patent/ES2177644T3/es not_active Expired - Lifetime
- 1995-04-11 AT AT95915264T patent/ATE221533T1/de not_active IP Right Cessation
- 1995-04-11 AU AU22206/95A patent/AU2220695A/en not_active Abandoned
- 1995-04-11 JP JP7526191A patent/JPH09511516A/ja not_active Ceased
- 1995-04-11 EP EP95915264A patent/EP0755398B1/en not_active Expired - Lifetime
-
1996
- 1996-10-11 NO NO964346A patent/NO964346L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH09511516A (ja) | 1997-11-18 |
ES2177644T3 (es) | 2002-12-16 |
EP0755398A1 (en) | 1997-01-29 |
DE69527617T2 (de) | 2003-04-10 |
NO964346D0 (no) | 1996-10-11 |
WO1995027713A1 (en) | 1995-10-19 |
US5811558A (en) | 1998-09-22 |
DE69527617D1 (de) | 2002-09-05 |
ATE221533T1 (de) | 2002-08-15 |
AU2220695A (en) | 1995-10-30 |
EP0755398B1 (en) | 2002-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO964346D0 (no) | Fremgangsmåte for opplösning av Etodolac ved bruk av glukaminderivater | |
MX9302214A (es) | Derivados de taxol y proceso para su preparacion | |
ATE128143T1 (de) | 17-beta-substituierte-4-aza-5-alpha-androstan-3 one-derivate und verfahren zu ihrer herstellung. | |
DE69525950T2 (de) | Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen | |
PT99794A (pt) | Processo para a preparacao de novas piperazinas 1,4-dissubstituidas | |
GEP20033044B (en) | Method for Treating Atherosclerosis | |
DZ1910A1 (fr) | Nouvelles streptogramines et procédé de préparation de streptogramines par mutasynthèse. | |
HUT77631A (hu) | Eljárás a levobupivakain és származékai rezolválására | |
HK1014927A1 (en) | Method of resolving racemic mixtures | |
NO308661B1 (no) | FremgangsmÕte for fremstilling av 5-acetamido-2,3,4,5- tetradeoksy-4-guanidino-D-glycero-D-galakto-non-2-enopyranosonsyre og en forbindelse til bruk ved fremgangsmÕten | |
SE9501808D0 (sv) | New process | |
ES2126313T3 (es) | Hidrolisis enzimatica de los 4-metiltiobutironitrilos. | |
SE9600086D0 (sv) | New manufacturing process | |
AU5644296A (en) | Novel heterocyclic chemistry | |
NO973366L (no) | Fremgangsmåte for behandling av multippel sklerose | |
NO982582L (no) | Fremgangsmaate for behandling av smerte | |
DE69607113D1 (de) | Verfahren zur Racemisierung von optisch aktiven 1-Phenylethylamin-Derivaten | |
PT793666E (pt) | Processo de sililacao | |
DE69405292D1 (de) | 6-Piperazinyl-1H-pyrazolo(3,4-b)pyridin-3-carbonsäuren, ihre Ester, Amide und verwandte Verbindungen, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
BR0008586A (pt) | Processo de preparação de aminoácidos quirais e processo de preparação de compostos a partir destes | |
DE59509946D1 (de) | Verfahren zur herstellung eines beta-aminoalkohols | |
DE69414586D1 (de) | Verfahren zur herstellung von indolizinderivaten | |
ES2056657T3 (es) | Derivado de la beta-fenilisoserina, su preparacion y su empleo. | |
ATE154022T1 (de) | Verfahren zur herstellung von epibatidin | |
SE9801726D0 (sv) | New process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |